HUP0202167A2 - Calcilytic compounds - Google Patents

Calcilytic compounds

Info

Publication number
HUP0202167A2
HUP0202167A2 HU0202167A HUP0202167A HUP0202167A2 HU P0202167 A2 HUP0202167 A2 HU P0202167A2 HU 0202167 A HU0202167 A HU 0202167A HU P0202167 A HUP0202167 A HU P0202167A HU P0202167 A2 HUP0202167 A2 HU P0202167A2
Authority
HU
Hungary
Prior art keywords
calcilytic compounds
calcilytic
compounds
Prior art date
Application number
HU0202167A
Other languages
Hungarian (hu)
Inventor
John Fox
Maxine Gowen
Edward F Nemeth
George B Stroup
Larry J Suva
Original Assignee
Nps Pharma Inc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc, Smithkline Beecham Corp filed Critical Nps Pharma Inc
Publication of HUP0202167A2 publication Critical patent/HUP0202167A2/en
Publication of HUP0202167A3 publication Critical patent/HUP0202167A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0202167A 1999-07-31 2000-07-31 Calcilytic compounds HUP0202167A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31

Publications (2)

Publication Number Publication Date
HUP0202167A2 true HUP0202167A2 (en) 2002-10-28
HUP0202167A3 HUP0202167A3 (en) 2006-07-28

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202167A HUP0202167A3 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Country Status (21)

Country Link
EP (1) EP1200076A4 (en)
JP (1) JP2003505502A (en)
KR (1) KR20020016928A (en)
CN (1) CN1367687A (en)
AU (1) AU764716B2 (en)
BR (1) BR0012921A (en)
CA (1) CA2380081A1 (en)
CO (1) CO5180628A1 (en)
CZ (1) CZ2002360A3 (en)
EC (1) ECSP003590A (en)
HK (1) HK1046238A1 (en)
HU (1) HUP0202167A3 (en)
IL (1) IL147875A0 (en)
MX (1) MXPA02001204A (en)
NO (1) NO20020466L (en)
PE (1) PE20010459A1 (en)
PL (1) PL353318A1 (en)
TR (1) TR200200278T2 (en)
UY (1) UY26265A1 (en)
WO (1) WO2001008673A1 (en)
ZA (1) ZA200200784B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY159417A (en) * 2000-01-24 2017-01-13 Smithkline Beecham Corp Calcilytic compounds
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AR042132A1 (en) 2002-11-26 2005-06-08 Smithkline Beecham Corp COMPOUND OF 2- HYDROXI -3- (2- ARIL - 1, 1 - DIMETHYLETHYLAMINE) PROPOXIFENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES IT TO PREPARE IT
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
UY30801A1 (en) 2006-12-18 2008-07-03 Smithkline Beecham Corp CALCILITICAL COMPOUNDS
WO2013098588A1 (en) * 2011-12-27 2013-07-04 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (en) * 2017-02-15 2018-08-21 四川大学 A kind of NPS-2143 is used for the new application of antibacterial
CN116173187B (en) * 2023-03-14 2024-05-10 哈尔滨医科大学 Application of calcitonin in preparation of medicine for preventing and treating restenosis in stent, medicine coating stent and preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332068A (en) * 1996-04-09 2001-03-30 Smithkline Beecham Alpha, alpha-disubstituted arylalkylamine derivatives as calcilytic compounds
PE20000415A1 (en) * 1998-04-08 2000-05-21 Smithkline Beecham Corp CALCILITIC COMPOUNDS
AR014975A1 (en) * 1998-04-08 2001-04-11 Nps Pharma Inc CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
ECSP003590A (en) 2002-02-25
TR200200278T2 (en) 2002-06-21
CZ2002360A3 (en) 2002-10-16
AU764716B2 (en) 2003-08-28
CO5180628A1 (en) 2002-07-30
JP2003505502A (en) 2003-02-12
NO20020466L (en) 2002-03-20
IL147875A0 (en) 2002-08-14
PL353318A1 (en) 2003-11-17
NO20020466D0 (en) 2002-01-29
HUP0202167A3 (en) 2006-07-28
WO2001008673A1 (en) 2001-02-08
ZA200200784B (en) 2003-01-29
BR0012921A (en) 2002-06-18
MXPA02001204A (en) 2004-05-21
CA2380081A1 (en) 2001-02-08
UY26265A1 (en) 2001-03-16
EP1200076A1 (en) 2002-05-02
KR20020016928A (en) 2002-03-06
HK1046238A1 (en) 2003-01-03
PE20010459A1 (en) 2001-06-11
EP1200076A4 (en) 2005-02-09
AU6504100A (en) 2001-02-19
CN1367687A (en) 2002-09-04

Similar Documents

Publication Publication Date Title
PL352911A1 (en) New compounds
GB2357761B (en) Compounds
HK1042303A1 (en) New compounds
EG24178A (en) Calcilytic compounds
EP1104411A4 (en) Calcilytic compounds
IL144470A0 (en) Calcilytic compounds
IL147875A0 (en) Calcilytic compounds
PL356140A1 (en) New compounds
AU7692301A (en) Calcilytic compounds
IL150398A0 (en) Calcilytic compounds
IL155522A0 (en) Calcilytic compounds
EP1112073A4 (en) Calcilytic compounds
GB9902399D0 (en) Compounds
HUP9904624D0 (en) New compounds
SI1202994T1 (en) New compounds
GB9901929D0 (en) Compounds
GB9903269D0 (en) Compounds
GB9901425D0 (en) Compounds
GB9903239D0 (en) Compounds
GB9903241D0 (en) Compounds
GB9903266D0 (en) Compounds
GB9903268D0 (en) Compounds
GB9901429D0 (en) Compounds
GB9903271D0 (en) Compounds
GB9903272D0 (en) Compounds

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished